Content |
Owners
History
2025: Pharmsintez transferred 1.5% of Pharmasintez-Medtech to its general director Nikolai Panikarovsky
The structure of ownership of the project company Pharmasintez-Medtech LLC has changed. JSC Pharmasinthesis"," which owned 49%, transferred 1.5% to General Director Nikolai Panikarovsky. Pharmasintez-Medtech was established in 2023 as a company for the construction of a new plant Kaluga region in the production of medical devices for hemodialysis and peritonal dialysis. The controlling stake of the company in 51% remained with the president of the Pharmasintez group Vikram Punia. The corresponding entry appeared in the Unified State Register of Legal Entities in September 2025.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |